Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Sihuan Pharma Prices Hong Kong IPO at Top of Range

publication date: Oct 22, 2010
Sihuan Pharmaceutical Holdings priced its IPO at HK$4.60, the high end of its range (HK$3.88 to HK$4.60) and, ironically, the same number as its Hong Kong exchange symbol, as though the price was somehow foreordained. The offering placed 1.25 billion shares, raising HK$5.75 billion ($741 million), a price that gives the company a P/E ratio of 26.7 times expected 2011 earnings. More details....

Stock Symbol: (HKEX: 0460)


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital